Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension —Real World Data of the Polish Lymphoma Research Group
This study aimed to assess the long-term prognostic value of arterial hypertension (AH) in diffuse large B-cell lymphoma (DLBCL). (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 13, 2024 Category: Cardiology Authors: Sebastian Szmit, Monika D ługosz-Danecka, Joanna Drozd-Sokołowska, Monika Joks, Agnieszka Szeremet, Artur Jurczyszyn, Wojciech Jurczak Tags: Original Article Source Type: research
Optimal Percutaneous Treatment Approach to Unprotected Ostial Left Anterior Descending Artery Disease: A Meta-Analysis and Systematic Review
The optimal management strategy for significant unprotected ostial left anterior descending artery (LAD) disease remains undefined. Merits of the two most common percutaneous approaches are considered in this quantitative synthesis. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 12, 2024 Category: Cardiology Authors: Han Shi, Kais Hyasat, Tejas Deshmukh, Cuneyt Ada, Joseph Chiha, Kaleab Asrress, Kevin Liou Tags: Review Source Type: research
Characteristics and Outcomes of a Single-Centre Cohort of Adult Congenital Heart Disease Patients Referred for Heart Transplant
Adult congenital heart disease (ACHD) services increasingly encounter heart failure (HF) in the ageing ACHD population. Optimal timing of referral for heart transplant (HTx) evaluation in this heterogeneous population is complex and ill-defined. We aim to outline the characteristics and outcomes of ACHD patients referred for HTx from a large Australian ACHD centre. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 11, 2024 Category: Cardiology Authors: Pavithra S. Jayadeva, Stacey Peters, Su Ling Tee, Luke J. Burchill, Silvana F. Marasco, Leeanne Grigg, Angeline Leet, David McGiffin, Dominica Zentner Tags: Original Article Source Type: research
Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care System
This study aimed to assess the cost-effectiveness of CMR-based surveillance in the first year after heart transplantation. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 11, 2024 Category: Cardiology Authors: Jim Pouliopoulos, Chris Anthony, Muhammad Imran, Robert M. Graham, Jane McCrohon, Cameron Holloway, Eugene Kotlyar, Kavitha Muthiah, Anne M. Keogh, Christopher S. Hayward, Peter S. Macdonald, Andrew Jabbour Tags: Original Article Source Type: research
Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer
It has been postulated that cancer hampers the delivery of guideline-directed medical therapy (GDMT) for heart failure (HF). However, few data are available in this regard. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 11, 2024 Category: Cardiology Authors: Giacomo Tini, Silvia Tanda, Matteo Toma, Allegra Battistoni, Beatrice Musumeci, Emanuele Barbato, Marco Canepa, Pietro Ameri Tags: Original Article Source Type: research
Thoracoscopic Left Atrial Appendage Occlusion with the AtriClip PRO2: An Experience of 144 Patients
To report the clinical outcomes of thoracoscopic left atrial appendage occlusion (LAAO) with the AtriClip PRO2 device (Atricure Inc, Mason, OH, USA). Stroke risk reduction with LAAO in patients with atrial fibrillation is now well-established. Many surgical and percutaneous techniques have been used, with varying rates of success. The percutaneous devices have had issues with procedural complications and peridevice flow. Thoracoscopic AtriClip offers an epicardial linear closure of the appendage at its ostium. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 10, 2024 Category: Cardiology Authors: Edward Wang, Paul Sadleir, Vijay Sourinathan, Rukshen Weerasooriya, David Playford, Pragnesh Joshi Tags: Original Article Source Type: research
The Effect of Pulmonary Hypertension on Mortality and Intensive Care Unit Admission in Patients With SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis
Severe COVID-19 can cause acute respiratory distress syndrome, hypoxia, systemic complications, and increased mortality. Pulmonary hypertension (PH) is a major global health issue associated with worsening symptoms and increased mortality. This systematic review aimed to assess the influence of PH onset among COVID-19 patients on all-cause mortality and intensive care unit (ICU) admission. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 9, 2024 Category: Cardiology Authors: Stefanos T. Papageorgiou, Savvas Damdoumis, Dimitrios Goulis, Stergios Tzikas, Georgios Giannakoulas Tags: ORIGINAL ARTICLE Source Type: research
Successful Implementation of Enhanced Recovery After Surgery (ERAS) in Paediatric Cardiac Surgery in Australia
We present the first structured implementation of ERAS in paediatric cardiac surgery in Australia. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 8, 2024 Category: Cardiology Authors: Shalom Andugala, Amy McIntosh, Jennifer Orchard, Sarfaraz Rahiman, Anna Miedecke, Janelle Keyser, Kim Betts, Supreet Marathe, Nelson Alphonso, Prem Venugopal Tags: Original Article Source Type: research
Is Transcatheter Aortic Valve Implantation (TAVI) Activity in Australia Consistent With International Guidelines?
This study was undertaken to provide an update on the status of TAVI activity in Australia. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 6, 2024 Category: Cardiology Authors: Jonathon B. Ryan, Peter W. Grant Tags: Original Article Source Type: research
The Role of Comorbidities in Predicting Functional Improvement After Transcatheter Aortic Valve Implantation
Patients undergoing transcatheter aortic valve implantation (TAVI) have a high comorbidity burden. We sought to stratify patients into functional outcomes using the Kansas City Cardiomyopathy Questionnaire (KCCQ-12), a patient-reported outcome with benefits over both the New York Heart Association (NYHA) classification and the original 23-item KCCQ, and to evaluate the importance of comorbidities in predicting failure of functional improvement post-TAVI in a contemporary cohort. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 5, 2024 Category: Cardiology Authors: Emma K. Gard, Samer Noaman, Dion Stub, Pieter Vriesendorp, Nay Htun, Rozanne Johnston, Elisha Gartner, Ronald Dick, Antony Walton, David Kaye, Shane Nanayakkara Tags: Original Article Source Type: research
Evaluating the Use of Unfractionated Heparin with Intra-Aortic Balloon Counterpulsation
Evidence supporting anticoagulation with unfractionated heparin (UFH) in patients with an intra-aortic balloon pump (IABP) to prevent limb ischaemia remains limited, while bleeding risks remain high. Monitoring heparin in this setting with anti-factor Xa (anti-Xa) is not previously described. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 4, 2024 Category: Cardiology Authors: Olivia Nuti, Cristian Merchan, John Papadopoulos, James Horowitz, Sunil V. Rao, Tania Ahuja Tags: Original Article Source Type: research
Incidence and Predictors of Readmissions to Non-Index Hospitals After Transcatheter Aortic Valve Implantation in the Contemporary Era in New South Wales, Australia
In Australia, transcatheter aortic valve implantation (TAVI) is only performed in a limited number of specialised metropolitan centres, many of which are private hospitals, making it likely that TAVI patients who require readmission will present to another (non-index) hospital. It is important to understand the impact of non-index readmission on patient outcomes and healthcare resource utilisation. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 4, 2024 Category: Cardiology Authors: Md Shajedur Rahman Shawon, Jonathon B. Ryan, Louisa Jorm Tags: Original Article Source Type: research
Preoperative Variables of 30-Day Mortality in Adults Undergoing Percutaneous Coronary Intervention: A Systematic Review
Risk adjustment following percutaneous coronary intervention (PCI) is vital for clinical quality registries, performance monitoring, and clinical decision-making. There remains significant variation in the accuracy and nature of risk adjustment models utilised in international PCI registries/databases. Therefore, the current systematic review aims to summarise preoperative variables associated with 30-day mortality among patients undergoing PCI, and the other methodologies used in risk adjustments. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 2, 2024 Category: Cardiology Authors: Mohammad Rocky Khan Chowdhury, Dion Stub, Diem Dinh, Md Nazmul Karim, Bodrun Naher Siddiquea, Baki Billah Tags: Review Source Type: research
2024 Australia –New Zealand Expert Consensus Statement on Cardiac Amyloidosis
Over the past 5 years, early diagnosis of and new treatments for cardiac amyloidosis (CA) have emerged that hold promise for early intervention. These include non-invasive diagnostic tests and disease modifying therapies. Recently, CA has been one of the first types of cardiomyopathy to be treated with gene editing techniques. Although these therapies are not yet widely available to patients in Australia and New Zealand, this may change in the near future. Given the rapid pace with which this field is evolving, it is important to view these advances within the Australian and New Zealand context. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 2, 2024 Category: Cardiology Authors: Nicole K. Bart, Diane Fatkin, James Gunton, James L. Hare, Dariusz Korczyk, Fiona Kwok, Kaitlyn Lam, David Russell, Hasib Sidiqi, Tim Sutton, Simon D.J. Gibbs, Peter Mollee, Liza Thomas Tags: Consensus Statement Source Type: research
Catheter Ablation for Atrial Fibrillation —Influence of Modifiable Risk Factors and Ablation Modality on Procedural Efficacy and Safety
Modifiable lifestyle risk factors, in particular obesity and related conditions, are important drivers of atrial fibrillation (AF), impacting the severity of symptoms and influence the efficacy and safety of treatment. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - April 2, 2024 Category: Cardiology Authors: Stephanie R. Sargent, Jordanna R. Mladenovic, Jacqueline J.T. Liaw, Jonathan Siller, Penni L. Russell, Matthew K.Y. Tung, David J. Holland Tags: Original Article Source Type: research
